Deciphering, Communicating, and Engineering the CRISPR PAM

Journal of Molecular Biology

Volumn 429, Issue 2, 2017, Pages 177-191

  Leenay, Ryan T ^a   Beisel, Chase L ^a  

^a North Carolina State University   (United States)

Author keywords

Cas9; Cpf1; CRISPR Cas systems; PFS; rPAM

Indexed keywords

CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; DNA; GUIDE RNA; BACTERIAL DNA; RNA;

CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; COMPUTER MODEL; DNA BINDING; DNA CLEAVAGE; DNA FLANKING REGION; GENETIC ENGINEERING; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR RECOGNITION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MOTIF; PROTOSPACER ADJACENT MOTIF; REVIEW; CRISPR CAS SYSTEM; GENE LIBRARY; GENE LOCUS; GENETICS; METABOLISM; PROTEIN ENGINEERING; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS THERMOPHILUS;

AMINO ACID MOTIFS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-CAS SYSTEMS; DNA, BACTERIAL; GENE LIBRARY; GENETIC LOCI; PLASMIDS; PROTEIN ENGINEERING; RNA; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS THERMOPHILUS;

EID: 85008608260     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2016.11.024     Document Type: Review

References (89)

1. [1] Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D.A., Horvath, P., CRISPR provides acquired resistance against viruses in prokaryotes. Science 315 (2007), 1709–1712, 10.1126/science.1138140.
2. [2] Doudna, J.A., Charpentier, E., The new frontier of genome engineering with CRISPR–Cas9. Science, 346, 2014, 1258096, 10.1126/science.1258096.
3. [3] Hsu, P.D., Lander, E.S., Zhang, F., Development and applications of CRISPR–Cas9 for genome engineering. Cell 157 (2014), 1262–1278, 10.1016/j.cell.2014.05.010.
4. [4] van der Oost, J., Westra, E.R., Jackson, R.N., Wiedenheft, B., Unravelling the structural and mechanistic basis of CRISPR–Cas systems. Nat. Rev. Microbiol. 12 (2014), 479–492, 10.1038/nrmicro3279.
5. [5] Barrangou, R., Doudna, J.A., Applications of CRISPR technologies in research and beyond. Nat. Biotechnol. 34 (2016), 933–941, 10.1038/nbt.3659.
6. [6] Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E., Norville, J.E., Church, G.M., RNA-guided human genome engineering via Cas9. Science 339 (2013), 823–826, 10.1126/science.1232033.RNA-Guided.
7. [7] Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, W., Marraffini, L.A., Zhang, F., Multiplex genome engineering using CRISPR/Cas systems. Science 339 (2013), 819–823, 10.1126/science.1231143.
8. [8] Bikard, D., Marraffini, L.A., Control of gene expression by CRISPR–Cas systems. F1000Prime Rep., 5(47), 2013, 10.12703/p5–47.
9. [9] Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., Charpentier, E., A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337 (2012), 816–822, 10.1126/science.1225829.
10. [10] Luo, M.L., Mullis, A.S., Leenay, R.T., Beisel, C.L., Repurposing endogenous type I CRISPR–Cas systems for programmable gene repression. Nucleic Acids Res. 43 (2014), 674–681, 10.1093/nar/gku971.
11. [11] Esvelt, K.M., Smidler, A.L., Catteruccia, F., Church, G.M., Concerning RNA-guided gene drives for the alteration of wild populations. Elife, 2014, e03401, 10.7554/eLife.03401.
12. [12] Hammond, A., Galizi, R., Kyrou, K., Simoni, A., Siniscalchi, C., Katsanos, D., Gribble, M., Baker, D., Marois, E., Russell, S., Burt, A., Windbichler, N., Crisanti, A., Nolan, T., A CRISPR–Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae. Nat. Biotechnol. 34 (2016), 78–83, 10.1038/nbt.3439.
13. [13] Bikard, D., Euler, C.W., Jiang, W., Nussenzweig, P.M., Goldberg, G.W., Duportet, X., Fischetti, V.A., Marraffini, L.A., Exploiting CRISPR–Cas nucleases to produce sequence-specific antimicrobials. Nat. Biotechnol. 32 (2014), 1146–1150, 10.1038/nbt.3043.
14. [14] Gomaa, A.A., Klumpe, H.E., Luo, M.L., Selle, K., Barrangou, R., Beisel, C., Programmable removal of bacterial strains by use of genome-targeting CRISPR–Cas systems. MBio, 5, 2014, e00928-13, 10.1128/mBio.00928–13.
15. [15] Anton, T., Bultmann, S., Leonhardt, H., Markaki, Y., Visualization of specific DNA sequences in living mouse embryonic stem cells with a programmable fluorescent CRISPR/Cas system. Nucleus 5 (2014), 163–172, 10.4161/nucl.28488.
16. [16] Chen, B., Gilbert, L.A., Cimini, B.A., Schnitzbauer, J., Zhang, W., Li, G., Park, J., Blackburn, E.H., Weissman, J.S., Lei, S., Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155 (2013), 1479–1491, 10.1016/j.cell.2013.12.001.Dynamic.
17. [17] Mohanraju, P., Makarova, K.S., Zetsche, B., Zhang, F., Koonin, E.V., Van der Oost, J., Diverse evolutionary roots and mechanistic variations of the CRISPR–Cas systems. Science, 353, 2016, aad5147, 10.1126/science.aad5147.
18. [18] Makarova, K.S., Wolf, Y.I., Alkhnbashi, O.S., Costa, F., Shah, S.A., Saunders, S.J., Barrangou, R., Brouns, S.J.J., Charpentier, E., Haft, D.H., Horvath, P., Moineau, S., Mojica, F.J.M., Terns, R.M., Terns, M.P., White, M.F., Yakunin, A.F., Garrett, R.A., van der Oost, J., Backofen, R., Koonin, E.V., An updated evolutionary classification of CRISPR–Cas systems. Nat. Rev. Microbiol. 13 (2015), 722–736, 10.1038/nrmicro3569.
19. [19] Shmakov, S., Abudayyeh, O.O., Makarova, K.S., Wolf, Y.I., Gootenberg, J.S., Semenova, E., Minakhin, L., Joung, J., Konermann, S., Severinov, K., Zhang, F., Koonin, E.V., Discovery and functional characterization of diverse class 2 CRISPR–Cas systems. Mol. Cell 60 (2015), 385–397, 10.1016/j.molcel.2015.10.008.
20. [20] Luo, M.L., Leenay, R.T., Beisel, C.L., Current and future prospects for CRISPR-based tools in bacteria. Biotechnol. Bioeng. 113 (2016), 930–943, 10.1002/bit.25851.
21. [21] Horvath, P., Romero, D.A., Coute-Monvoisin, A.-C., Richards, M., Deveau, H., Moineau, S., Boyaval, P., Fremaux, C., Barrangou, R., Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus. J. Bacteriol. 190 (2008), 1401–1412, 10.1128/JB.01415-07.
22. [22] Deveau, H., Barrangou, R., Garneau, J.E., Labonte, J., Fremaux, C., Boyaval, P., Romero, D.A., Horvath, P., Moineau, S., Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J. Bacteriol. 190 (2008), 1390–1400, 10.1128/JB.01412-07.
23. [23] Mojica, F.J.M., Diez-Villasenor, C., Garcia-Martinez, J., Almendros, C., Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 155 (2009), 733–740, 10.1099/mic.0.023960-0.
24. [24] Garneau, J.E., Dupuis, M.-È., Villion, M., Romero, D.a., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A.H., Moineau, S., The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468 (2010), 67–71, 10.1038/nature09523.
25. [25] Gasiunas, G., Barrangou, R., Horvath, P., Siksnys, V., Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), E2579–E2586, 10.1073/pnas.1208507109.
26. [26] Hale, C.R., Zhao, P., Olson, S., Duff, M.O., Graveley, B.R., Wells, L., Terns, R.M., Terns, M.P., RNA-guided RNA cleavage by a CRISPR RNA–Cas protein complex. Cell 139 (2009), 945–956, 10.1016/j.cell.2009.07.040.
27. [27] Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., Doudna, J., RNA-programmed genome editing in human cells. Elife., 2013, 2013, e00471, 10.7554/eLife.00471.
28. [28] Jore, M.M., Lundgren, M., van Duijn, E., Bultema, J.B., Westra, E.R., Waghmare, S.P., Wiedenheft, B., Pul, Ü., Wurm, R., Wagner, R., Beijer, M.R., Barendregt, A., Zhou, K., Snijders, A.P.L., Dickman, M.J., Doudna, J.A., Boekema, E.J., Heck, A.J.R., van der Oost, J., Brouns, S.J.J., Structural basis for CRISPR RNA-guided DNA recognition by Cascade. Nat. Struct. Mol. Biol. 18 (2011), 529–536, 10.1038/nsmb.2019.
29. [29] Westra, E.R., van Erp, P.B.G., Künne, T., Wong, S.P., Staals, R.H.J., Seegers, C.L.C., Bollen, S., Jore, M.M., Semenova, E., Severinov, K., de Vos, W.M., Dame, R.T., de Vries, R., Brouns, S.J.J., van der Oost, J., CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol. Cell 46 (2012), 595–605, 10.1016/j.molcel.2012.03.018.
30. [30] Mojica, F.J.M., Díez-Villaseñor, C., García-Martínez, J., Soria, E., Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J. Mol. Evol. 60 (2005), 174–182, 10.1007/s00239-004-0046-3.
31. [31] Jansen, R., Van Embden, J.D.A., Gaastra, W., Schouls, L.M., Identification of genes that are associated with DNA repeats in prokaryotes. Mol. Microbiol. 43 (2002), 1565–1575, 10.1046/j.1365-2958.2002.02839.x.
32. [32] Bolotin, A., Quinquis, B., Sorokin, A., Dusko Ehrlich, S., Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 151 (2005), 2551–2561, 10.1099/mic.0.28048-0.
33. [33] Carte, J., Wang, R., Li, H., Terns, R.M., Terns, M.P., Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. Genes Dev. 22 (2008), 3489–3496, 10.1101/gad.1742908.
34. [34] Brouns, S.J.J., Jore, M.M., Lundgren, M., Westra, E.R., Slijkhuis, R.J.H., Snijders, A.P.L., Dickman, M.J., Makarova, K.S., Koonin, E.V., van der Oost, J., Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321 (2008), 960–964, 10.1126/science.1159689.
35. [35] Deltcheva, E., Chylinski, K., Sharma, C.M., Gonzales, K., CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471 (2011), 602–607, 10.1038/nature09886.CRISPR.
36. [36] Burstein, D., Sun, C.L., Brown, C.T., Sharon, I., Anantharaman, K., Probst, A.J., Thomas, B.C., Banfield, J.F., Major bacterial lineages are essentially devoid of CRISPR–Cas viral defence systems. Nat. Commun., 7, 2016, 10613, 10.1038/ncomms10613.
37. [37] Makarova, K.S., Haft, D.H., Barrangou, R., Brouns, S.J.J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F.J.M., Wolf, Y.I., Yakunin, A.F., van der Oost, J., Koonin, E.V., Evolution and classification of the CRISPR–Cas systems. Nat. Rev. Microbiol. 9 (2011), 467–477, 10.1038/nrmicro2577.
38. [38] Chylinski, K., Makarova, K.S., Charpentier, E., Koonin, E.V., Classification and evolution of type II CRISPR–Cas systems. Nucleic Acids Res. 42 (2014), 6091–6105, 10.1093/nar/gku241.
39. [39] Abudayyeh, O.O., Gootenberg, J.S., Konermann, S., Joung, J., Slaymaker, I.M., Cox, D.B., Shmakov, S., Makarova, K.S., Semenova, E., Minakhin, L., Severinov, K., Regev, A., Lander, E.S., Koonin, E.V., Zhang, F., C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science, 353, 2016, aaf5573, 10.1101/054742.
40. [40] Elmore, J.R., Sheppard, N.F., Ramia, N., Deighan, T., Li, H., Terns, R.M., Terns, M.P., Bipartite recognition of target RNAs activates DNA cleavage by the type III-B CRISPR–Cas system. Genes Dev. 30 (2016), 447–459, 10.1101/gad.272153.115.
41. [41] Marraffini, L.A., Sontheimer, E.J., Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature 463 (2010), 568–571, 10.1038/nature08703.
42. [42] Wiedenheft, B., van Duijn, E., Bultema, J.B., Waghmare, S.P., Zhoua, K., Barendregt, A., Westphal, W., Heck, A.J.R., Boekema, E.J., Dickman, M.J., Douda, J., RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc. Natl. Acad. Sci., 108, 2011, 15010, 10.1073/pnas.1111854108.
43. [43] Mulepati, S., Héroux, A., Bailey, S., Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssDNA target. Science 345 (2014), 1479–1484, 10.1126/science.1256996.
44. [44] Jinek, M., Jiang, F., Taylor, D.W., Sternberg, S.H., Kaya, E., Ma, E., Anders, C., Hauer, M., Zhou, K., Lin, S., Kaplan, M., Iavarone, A.T., Charpentier, E., Nogales, E., Doudna, J.A., Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science, 343, 2014, 1247997, 10.1126/science.1247997.
45. [45] Nishimasu, H., Ran, F.A., Hsu, P.D., Konermann, S., Shehata, S.I., Dohmae, N., Ishitani, R., Zhang, F., Nureki, O., Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156 (2014), 935–949, 10.1016/j.cell.2014.02.001.
46. [46] Anders, C., Niewoehner, O., Duerst, A., Jinek, M., Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513 (2014), 569–573, 10.1038/nature13579.
47. [47] Sternberg, S.H., Redding, S., Jinek, M., Greene, E.C., Doudna, J., DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 507 (2014), 62–67, 10.1038/nature13011.
48. [48] Yosef, I., Shitrit, D., Goren, M.G., Burstein, D., Pupko, T., Qimron, U., DNA motifs determining the efficiency of adaptation into the Escherichia coli CRISPR array. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 14396–14401, 10.1073/pnas.1300108110.
49. [49] Savitskaya, E., Semenova, E., Dedkov, V., Metlitskaya, A., Severinov, K., High-throughput analysis of type I-E CRISPR/Cas spacer acquisition in E. coli. RNA Biol. 10 (2013), 716–725, 10.4161/rna.24325.
50. [50] Levy, A., Goren, M.G., Yosef, I., Auster, O., Manor, M., Amitai, G., Edgar, R., Qimron, U., Sorek, R., CRISPR adaptation biases explain preference for acquisition of foreign DNA. Nature 520 (2015), 505–510, 10.1038/nature14302.
51. [51] Heler, R., Samai, P., Modell, J.W., Weiner, C., Goldberg, G.W., Bikard, D., Marraffini, L.A., Cas9 specifies functional viral targets during CRISPR–Cas adaptation. Nature 519 (2015), 199–202, 10.1038/nature14245.
52. [52] Wei, Y., Terns, R.M., Terns, M.P., Terns, M.P., Terns, M.P., Cas9 function and host genome sampling in type II-A CRISPR–cas adaptation. Genes Dev. 29 (2015), 356–361, 10.1101/gad.257550.114.
53. [53] Kunne, T., Kieper, S.N., Bannenberg, J.W., Depken, M., Suarez-diez, M., Brouns, S.J.J., Ku, T., Kieper, S.N., Bannenberg, J.W., Vogel, A.I.M., Miellet, W.R., Klein, M., Cas3-derived target DNA degradation fragments fuel primed CRISPR adaptation. Mol. Cell 63 (2016), 852–864, 10.1016/j.molcel.2016.07.011.
54. [54] Xue, C., Seetharam, A.S., Musharova, O., Severinov, K., Brouns, S.J.J., Severin, A.J., Sashital, D.G., CRISPR interference and priming varies with individual spacer sequences. Nucleic Acids Res. 43 (2015), 10831–10847, 10.1093/nar/gkv1259.
55. [55] Xue, C., Whitis, N.R., Sashital, D.G., Xue, C., Whitis, N.R., Sashital, D.G., Conformational control of Cascade interference and priming activities in CRISPR immunity. Mol. Cell 64 (2016), 826–834, 10.1016/j.molcel.2016.09.033.
56. [56] Mojica, F.J.M., Díez-Villaseñor, C., Right of admission reserved, no matter the path. Trends Microbiol. 21 (2013), 446–448, 10.1016/j.tim.2013.06.003.
57. [57] Shah, S., Erdmann, S., Mojica, F., Garrett, R., Protospacer recognition motifs: mixed identities and functional diversity. RNA Biol. 10 (2013), 891–899, 10.4161/rna.23764.
58. [58] Semenova, E., Jore, M.M., Datsenko, K.A., Semenova, A., Westra, E.R., Wanner, B., van der Oost, J., Brouns, S.J.J., Severinov, K., Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 10098–10103, 10.1073/pnas.1104144108.
59. [59] Elmore, J., Deighan, T., Westpheling, J., Terns, R.M., Terns, M.P., DNA targeting by the type I-G and type I-A CRISPR–Cas systems of Pyrococcus furiosus. Nucleic Acids Res., 43, 2015, 10353–10363, 10.1093/nar/gkv1140 (gkv1140).
60. [60] Jiang, W., Bikard, D., Cox, D., Zhang, F., Marraffini, L.A., RNA-guided editing of bacterial genomes using CRISPR–Cas systems. Nat. Biotechnol. 31 (2013), 233–239, 10.1038/nbt.2508.
61. [61] Esvelt, K.M., Mali, P., Braff, J.L., Moosburner, M., Yaung, S.J., Church, G.M., Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat. Methods 10 (2013), 1116–1121, 10.1038/nmeth.2681.
62. [62] Briner, A.E., Donohoue, P.D., Gomaa, A.A., Selle, K., Slorach, E.M., Nye, C.H., Haurwitz, R.E., Beisel, C.L., May, A.P., Barrangou, R., Guide RNA functional modules direct Cas9 activity and orthogonality. Mol. Cell 56 (2014), 333–339, 10.1016/j.molcel.2014.09.019.
63. [63] Westra, E.R., Semenova, E., Datsenko, K.A., Jackson, R.N., Wiedenheft, B., Severinov, K., Brouns, S.J.J., Type I-E CRISPR–Cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition. PLoS Genet., 9, 2013, e1003742, 10.1371/journal.pgen.1003742.
64. [64] Leenay, R.T., Maksimchuk, K.R., Slotkowski, R.A., Agrawal, R.N., Gomaa, A.A., Briner, A.E., Barrangou, R., Beisel, C.L., Identifying and visualizing functional PAM diversity across CRISPR–Cas systems. Mol. Cell 62 (2016), 137–147, 10.1016/j.molcel.2016.02.031.
65. [65] Ran, F.A., Cong, L., Yan, W.X., Scott, D.A., Gootenberg, J.S., Kriz, A.J., Zetsche, B., Shalem, O., Wu, X., Makarova, K.S., Koonin, E.V., Sharp, P.A., Zhang, F., In vivo genome editing using Staphylococcus aureus Cas9. Nature 520 (2015), 186–190, 10.1038/nature14299.
66. [66] Altschul, S.F., Gish, W., Miller, W., Myers, E.W., Lipman, D.J., Basic local alignment search tool. J. Mol. Biol. 215 (1990), 403–410, 10.1016/S0022-2836(05)80360-2.
67. [67] Biswas, A., Gagnon, J.N., Brouns, S.J.J., Fineran, P.C., Brown, C.M., CRISPRTarget: Bioinformatic prediction and analysis of crRNA targets. RNA Biol. 10 (2013), 817–827, 10.4161/rna.24046.
68. [68] Shipman, S.L., Shipman, S.L., Nivala, J., Macklis, J.D., Church, G.M., Molecular recordings by directed CRISPR spacer acquisition. Science, 1175, 2016, aaf1175, 10.1126/science.aaf1175.
69. [69] Zetsche, B., Gootenberg, J.S., Abudayyeh, O.O., Slaymaker, I.M., Makarova, K.S., Essletzbichler, P., Volz, S.E., Joung, J., van der Oost, J., Regev, A., Koonin, E.V., Zhang, F., Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR–Cas system. Cell 163 (2015), 759–771, 10.1016/j.cell.2015.09.038.
70. [70] Pattanayak, V., Lin, S., Guilinger, J.P., Ma, E., Doudna, J.A., Liu, D.R., High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol. 31 (2013), 839–843, 10.1038/nbt.2673.
71. [71] Karvelis, T., Gasiunas, G., Young, J., Bigelyte, G., Silanskas, A., Cigan, M., Siksnys, V., Rapid characterization of CRISPR–Cas9 protospacer adjacent motif sequence elements. Genome Biol., 16, 2015, 253, 10.1186/s13059-015-0818-7.
72. [72] Kleinstiver, B.P., Prew, M.S., Tsai, S.Q., Topkar, V.V., Nguyen, N.T., Zheng, Z., Gonzales, A.P.W., Li, Z., Peterson, R.T., Yeh, J.-R.J., Aryee, M.J., Joung, J.K., Engineered CRISPR–Cas9 nucleases with altered PAM specificities. Nature 523 (2015), 481–485, 10.1038/nature14592.
73. [73] Fonfara, I., Richter, H., Bratovič, M., Le Rhun, A., Charpentier, E., The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature 532 (2016), 517–521, 10.1038/nature17945.
74. [74] Boyle, E.A., Andreasson, J.O.L., Lauren, M., Sternberg, S.H., Wu, M.J., Chantal, K., Doudna, J.A., Greenleaf, W.J., High-throughput biochemical profiling reveals Cas9 off-target binding and unbinding heterogeneity. bioRxiv, 2016, 10.1101/059782.
75. [75] Ondov, B.D., Bergman, N.H., Phillippy, A.M., Interactive metagenomic visualization in a Web browser. BMC Bioinformatics, 12, 2011, 10.1186/1471–2105–12-385.
76. [76] Kleinstiver, B.P., Prew, M.S., Tsai, S.Q., Nguyen, N.T., Topkar, V.V., Zheng, Z., Joung, J.K., Broadening the targeting range of Staphylococcus aureus CRISPR–Cas9 by modifying PAM recognition. Nat. Biotechnol. 33 (2015), 1293–1298, 10.1038/nbt.3404.
77. [77] Anders, C., Bargsten, K., Jinek, M., Structural plasticity of PAM recognition by engineered variants of the RNA-guided endonuclease Cas9. Mol. Cell 61 (2016), 895–902, 10.1016/j.molcel.2016.02.020.
78. [78] Dong, D., Ren, K., Qiu, X., Zheng, J., Guo, M., Guan, X., Liu, H., Li, N., Zhang, B., Yang, D., Ma, C., Wang, S., Wu, D., Ma, Y., Fan, S., Wang, J., Gao, N., Huang, Z., The crystal structure of Cpf1 in complex with CRISPR RNA. Nature 532 (2016), 522–526, 10.1038/nature17944.
79. [79] Nishimasu, H., Cong, L., Winston, X., Nishimasu, H., Cong, L., Yan, W.X., Ran, F.A., Zetsche, B., Li, Y., Crystal structure of Staphylococcus aureus Cas9. Cell 162 (2015), 1113–1126, 10.1016/j.cell.2015.08.007.
80. [80] Jackson, R.N., Golden, S.M., van Erp, P.B.G., Carter, J., Westra, E.R., Brouns, S.J.J., van der Oost, J., Terwilliger, T.C., Read, R.J., Wiedenheft, B., Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli. Science 345 (2014), 1473–1479, 10.1126/science.1256328.
81. [81] Tsai, S.Q., Zheng, Z., Nguyen, N.T., Liebers, M., Topkar, V.V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A.J., Le, L.P., Aryee, M.J., Joung, J.K., GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR–Cas nucleases. Nat. Biotechnol. 33 (2015), 187–197, 10.1038/nbt.3117.
82. [82] Yosef, I., Goren, M.G., Qimron, U., Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res. 40 (2012), 5569–5576, 10.1093/nar/gks216.
83. [83] Nuñez, J.K., Kranzusch, P.J., Noeske, J., Wright, A.V., Davies, C.W., Doudna, J.A., Cas1–Cas2 complex formation mediates spacer acquisition during CRISPR–Cas adaptive immunity. Nat. Struct. Mol. Biol. 21 (2014), 528–534, 10.1038/nsmb.2820.
84. [84] Datsenko, K.a., Pougach, K., Tikhonov, A., Wanner, B.L., Severinov, K., Semenova, E., Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat. Commun., 3, 2012, 945, 10.1038/ncomms1937.
85. [85] Kleinstiver, B.P., Pattanayak, V., Prew, M.S., Tsai, S.Q., Nguyen, N.T., Zheng, Z., Keith Joung, J., High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529 (2016), 490–495, 10.1038/nature16526.
86. [86] Slaymaker, I.M., Gao, L., Zetsche, B., Scott, D.A., Yan, W.X., Zhang, F., Rationally engineered Cas9 nucleases with improved specificity. Science 351 (2015), 84–88, 10.1126/science.aad5227.
87. [87] Boudry, P., Semenova, E., Monot, M., Datsenko, K.A., Lopatina, A., Sekulovic, O., Ospina-Bedoya, M., Severinov, L.-C.F.K., Dupuy, B., Soutourinaa, O., Function of the CRISPR–Cas system of the human pathogen Clostridium difficile. MBio 6 (2015), e01112–e01115, 10.1128/mBio.01112-15.Editor.
88. [88] Cady, K.C., Bondy-Denomy, J., Heussler, G.E., Davidson, A.R., O'Toole, G.A., The CRISPR/cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages. J. Bacteriol. 194 (2012), 5728–5738, 10.1128/JB.01184-12.
89. [89] Crooks, G., Hon, G., Chandonia, J., Brenner, S., WebLogo: a sequence logo generator. Genome Res. 14 (2004), 1188–1190, 10.1101/gr.849004.1.